165 related articles for article (PubMed ID: 24642343)
1. Increased serum autotaxin levels in hepatocellular carcinoma patients were caused by background liver fibrosis but not by carcinoma.
Kondo M; Ishizawa T; Enooku K; Tokuhara Y; Ohkawa R; Uranbileg B; Nakagawa H; Tateishi R; Yoshida H; Kokudo N; Koike K; Yatomi Y; Ikeda H
Clin Chim Acta; 2014 Jun; 433():128-34. PubMed ID: 24642343
[TBL] [Abstract][Full Text] [Related]
2. Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels.
Enooku K; Uranbileg B; Ikeda H; Kurano M; Sato M; Kudo H; Maki H; Koike K; Hasegawa K; Kokudo N; Yatomi Y
PLoS One; 2016; 11(9):e0161825. PubMed ID: 27583415
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
[TBL] [Abstract][Full Text] [Related]
4. Expression of autotaxin mRNA in human hepatocellular carcinoma.
Zhang G; Zhao Z; Xu S; Ni L; Wang X
Chin Med J (Engl); 1999 Apr; 112(4):330-2. PubMed ID: 11593532
[TBL] [Abstract][Full Text] [Related]
5. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
Kremer AE; van Dijk R; Leckie P; Schaap FG; Kuiper EM; Mettang T; Reiners KS; Raap U; van Buuren HR; van Erpecum KJ; Davies NA; Rust C; Engert A; Jalan R; Oude Elferink RP; Beuers U
Hepatology; 2012 Oct; 56(4):1391-400. PubMed ID: 22473838
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte autotaxin expression promotes liver fibrosis and cancer.
Kaffe E; Katsifa A; Xylourgidis N; Ninou I; Zannikou M; Harokopos V; Foka P; Dimitriadis A; Evangelou K; Moulas AN; Georgopoulou U; Gorgoulis VG; Dalekos GN; Aidinis V
Hepatology; 2017 Apr; 65(4):1369-1383. PubMed ID: 27981605
[TBL] [Abstract][Full Text] [Related]
7. Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C.
Takemura K; Takizawa E; Tamori A; Nakamae M; Kubota H; Uchida-Kobayashi S; Enomoto M; Kawada N; Hino M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630450
[TBL] [Abstract][Full Text] [Related]
8. Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.
Farquhar MJ; Humphreys IS; Rudge SA; Wilson GK; Bhattacharya B; Ciaccia M; Hu K; Zhang Q; Mailly L; Reynolds GM; Ashcroft M; Balfe P; Baumert TF; Roessler S; Wakelam MJO; McKeating JA
J Hepatol; 2017 May; 66(5):919-929. PubMed ID: 28126468
[TBL] [Abstract][Full Text] [Related]
9. Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis C.
Takemura K; Takizawa E; Tamori A; Nakamae M; Kubota H; Uchida-Kobayashi S; Enomoto M; Kawada N; Hino M
J Gastroenterol Hepatol; 2021 Jan; 36(1):217-224. PubMed ID: 32453907
[TBL] [Abstract][Full Text] [Related]
10. [A study on expression of autotaxin mRNA in hepatocellular carcinoma].
Zhao Z; Xu S; Zhang G
Zhonghua Gan Zang Bing Za Zhi; 1999 Sep; 7(3):140-1. PubMed ID: 10572678
[TBL] [Abstract][Full Text] [Related]
11. Autotaxin in liver fibrosis.
Ikeda H; Yatomi Y
Clin Chim Acta; 2012 Nov; 413(23-24):1817-21. PubMed ID: 22820036
[TBL] [Abstract][Full Text] [Related]
12. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C
Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226
[TBL] [Abstract][Full Text] [Related]
13. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: safety and efficacy in comparison with radiofrequency ablation.
Simo KA; Sereika SE; Newton KN; Gerber DA
J Surg Oncol; 2011 Dec; 104(7):822-9. PubMed ID: 21520094
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of liver resection for hepatocellular carcinoma in noncirrhotic liver.
Faber W; Sharafi S; Stockmann M; Denecke T; Sinn B; Puhl G; Bahra M; Malinowski MB; Neuhaus P; Seehofer D
Surgery; 2013 Apr; 153(4):510-7. PubMed ID: 23122930
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation for the treatment of hepatocellular carcinoma with decompensated cirrhosis.
Wakuta A; Nouso K; Kariyama K; Nishimura M; Kishida M; Wada N; Mizushima T; Higashi T; Tanimoto M
Oncology; 2011; 81(1):39-44. PubMed ID: 21912196
[TBL] [Abstract][Full Text] [Related]
17. Performance status enhances the selection of treatment for patients with hepatocellular carcinoma within the milan criteria.
Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Lin HC; Chiou YY; Lee FY; Huo TI
Ann Surg Oncol; 2013 Jun; 20(6):2035-42. PubMed ID: 23306955
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of hepatocellular carcinoma in patients with decompensated cirrhosis: evaluation of therapeutic efficacy and safety.
Kim YK; Kim CS; Chung GH; Han YM; Lee SY; Jin GY; Lee JM
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S261-8. PubMed ID: 16632686
[TBL] [Abstract][Full Text] [Related]
19. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity.
Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Tomiya T; Tejima K; Nishikawa T; Arai M; Yanase M; Aoki J; Arai H; Omata M; Fujiwara K; Yatomi Y
Life Sci; 2007 Sep; 81(12):1009-15. PubMed ID: 17850827
[TBL] [Abstract][Full Text] [Related]
20. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
Ziol M; Sutton A; Calderaro J; Barget N; Aout M; Leroy V; Blanc JF; Sturm N; Bioulac-Sage P; Nahon P; Nault JC; Charnaux N; N'kontchou G; Trinchet JC; Delehedde M; Seror O; Beaugrand M; Vicaut E; Ganne-Carrié N
J Hepatol; 2013 Dec; 59(6):1264-70. PubMed ID: 23928407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
